Download PDF
Thromb Haemost 1981; 45(03): 294
DOI: 10.1055/s-0038-1650191
Letter to the Editor
Schattauer GmbH Stuttgart

Salicylate-Aspirin Interaction and Thrombosis Prevention Trials

C de Castellarnau
Istituto di Ricerche Farmacologiche, “Mario Negri”, Via Eritrea, 62, 20157 Milan, Italy
,
C Cerletti
Istituto di Ricerche Farmacologiche, “Mario Negri”, Via Eritrea, 62, 20157 Milan, Italy
,
E Dejana
Istituto di Ricerche Farmacologiche, “Mario Negri”, Via Eritrea, 62, 20157 Milan, Italy
,
F Galletti
Istituto di Ricerche Farmacologiche, “Mario Negri”, Via Eritrea, 62, 20157 Milan, Italy
,
R Latini
Istituto di Ricerche Farmacologiche, “Mario Negri”, Via Eritrea, 62, 20157 Milan, Italy
,
M Livio
Istituto di Ricerche Farmacologiche, “Mario Negri”, Via Eritrea, 62, 20157 Milan, Italy
,
G de Gaetano
Istituto di Ricerche Farmacologiche, “Mario Negri”, Via Eritrea, 62, 20157 Milan, Italy
› Author Affiliations
Further Information

Publication History

Received 26 January 1981

Accepted 10 March 1981

Publication Date:
06 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Moncada S, Vane JR. Prostacyclin, platelet aggregation and thrombosis. In: de GaetanoG, Garattini S. eds. Platelets: A Multidisciplinary Approach. New York: Raven Press; 1978: 239-259
    Google Scholar
  • 2 Burch JW, Baezinger NL, Stanford N, Majerus PW. Sensitivity of fatty acid cyclooxygenase from human aorta to acetylation by aspirin. Proc Natl Acad Sci 1978; 75: 5181-5184
    CrossrefPubMedGoogle Scholar
  • 3 Villa S, Livio M, de GaetanoG. The inhibitory effect of aspirin on platelet and vascular prostaglandin in rats cannot be completely dissociated. Br J Haematol 1979; 42: 425-431
    CrossrefPubMedGoogle Scholar
  • 4 Masotti G, Galanti G, Poggesi L, Abbate R, Neri Serneri GG. Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet 1979; 02: 1213-1217
    PubMedGoogle Scholar
  • 5 Editorial. Aspirin after myocardial infarction. Lancet 1980; 01: 1172-1173
    PubMedGoogle Scholar
  • 6 Vargaftig BB. The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines. Eur J Pharmacol 1978; 50: 231-241
    CrossrefPubMedGoogle Scholar
  • 7 Merino J, Livio M, Rajtar G, de GaetanoG. Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation. Biochem Pharmacol 1980; 29: 1093-1096
    CrossrefPubMedGoogle Scholar
  • 8 Ali M, McDonald JW D. Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity. Prostaglandins and Medicine 1979; 03: 327-332
    CrossrefPubMedGoogle Scholar
  • 9 Rowland M, Riegelman S, Harris PA, Sholkoff SD. Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J Pharm Sci 1972; 61: 379-385
    CrossrefPubMedGoogle Scholar
  • 10 Buchanan MR, Dejana E, Cazenave JP, Richardson M, Mustard JF, Hirsch J. Differences in inhibition of PGI2 production by aspirin in rabbit artery and vein segments. Thromb Res 1980; 20: 447-460
    CrossrefPubMedGoogle Scholar
  • 11 Lewy RI, Smith JB, Silver MJ, Saia J, Walinsky P, Wiener L. Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal’s angina. Prostaglandins and Medicine 1979; 05: 243-248
    PubMedGoogle Scholar
  • 12 Cotty VF, Ederma HM. Method for the direct measurement of acetylsalicylic acid in human blood. J Pharm Sci 1966; 55: 837-839
    CrossrefPubMedGoogle Scholar